Gallagher Cam

CIK 00015578323 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001557832

Recent Transactions

50 trades

Award
Opus Genetics, Inc.$IRD
Common Stock
2026-04-20+24,367→ 2,015,797 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2026-01-06+67,000→ 1,991,430 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2025-12-31+33,000→ 1,924,430 total
Purchase
Opus Genetics, Inc.$IRD
Common Stock
2025-12-29$1.97/sh+83,000→ 83,000 total
Purchase
Opus Genetics, Inc.$IRD
Common Stock
2025-12-29$1.98/sh+81,000→ 1,891,430 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2025-08-25$1.15/sh+869,565→ 1,810,430 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2025-04-30+79,504→ 940,865 total
Award
Opus Genetics, Inc.$IRD
Stock Option (Right to Buy)
2025-04-30+79,592→ 79,592 total
Award
Opus Genetics, Inc.$IRD
Warrants (right to buy)
2025-03-24+784,314→ 784,314 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2025-03-24+784,314→ 861,361 total
Award
Opus Genetics, Inc.$IRD
Stock Option (Right to Buy)
2024-06-11+35,181→ 35,181 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2024-06-11+41,143→ 77,047 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-05-31$11.98/sh−9,597→ 633,680 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-12$11.44/sh−1,173→ 643,277 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-02$11.54/sh−11,552→ 644,450 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2024-02-01+192,500→ 192,500 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-01+192,500→ 656,002 total
Award
Opus Genetics, Inc.$IRD
Stock Option
2023-06-06+9,639→ 9,639 total
Award
Opus Genetics, Inc.$IRD
Common Stock
2023-06-06+10,976→ 35,904 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-05-31$26.40/sh−9,242→ 482,028 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-05-31$26.21/sh−18,526→ 463,502 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-14$19.96/sh−8,501→ 491,270 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-13$20.42/sh−3,332→ 499,771 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-06$22.22/sh−9,428→ 503,675 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-06$23.04/sh−572→ 503,103 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2023-02-01+233,908→ 233,908 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-01+161,092→ 513,103 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-01-17$24.87/sh−500→ 352,011 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-01-17$24.11/sh−9,500→ 352,511 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-01-05$21.46/sh−300→ 362,011 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-01-05$21.01/sh−9,700→ 362,311 total
Exercise of In-Money
Opus Genetics, Inc.$IRD
Common Stock
2023-01-04$0.00/sh+1,574→ 24,928 total
Exercise of In-Money
Opus Genetics, Inc.$IRD
Series B Warrant (right to buy)
2023-01-04−1,574→ 0 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-11-15$22.72/sh−11,600→ 372,911 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-11-15$23.48/sh−900→ 372,011 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-11-08$23.56/sh−12,374→ 384,511 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-11-07$23.66/sh−12,343→ 397,042 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-11-07$24.24/sh−157→ 396,885 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-10-17$23.51/sh−12,500→ 409,385 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-10-06$22.62/sh−10,000→ 421,885 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-10-05$21.92/sh−7,004→ 437,381 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-10-05$22.83/sh−5,496→ 431,885 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-09-16$24.99/sh−1,134→ 444,385 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-09-16$24.38/sh−8,866→ 445,519 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-09-15$25.59/sh−4,074→ 454,385 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-09-15$25.10/sh−8,426→ 458,459 total
Award
Opus Genetics, Inc.$IRD
Stock Option (right to buy)
2022-06-13+20,000→ 20,000 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2022-05-30+333,218→ 333,218 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-05-30+111,072→ 466,885 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-04-05$51.59/sh−2,196→ 355,913 total

Companies

Recent Filings

Address

C/O OPUS GENETICS, INC. 8 DAVIS DRIVE, SUITE 220

DURHAM, NC, 27713

View on SEC.gov